|
|
Zebrafish Models of Cancer
|
ZIABC010549
|
$572,098
|
$114,420
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
7K08CA133103-05
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$36,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$4,500
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
Xenograft Model to Study Impact of CRLF2-Ligand in Hispanic Childhood B-ALL
|
1R21CA162259-01A1
|
$193,793
|
$193,793
|
PAYNE, KIMBERLY
|
LOMA LINDA UNIVERSITY
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$41,919
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$29,854
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$1,500
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$2,994
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-12
|
$1,428,925
|
$171,471
|
PIWNICA-WORMS, DAVID
|
WASHINGTON UNIVERSITY
|
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
2R01CA044722-22A1
|
$202,321
|
$202,321
|
Studzinski, George
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Outpatient Clinic File
|
ZIA CP010126-00580
|
$74,164
|
$7,416
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$2,799
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$7,982
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-02
|
$316,438
|
$316,438
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-04
|
$352,231
|
$352,231
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
5R33CA161731-02
|
$400,042
|
$400,042
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$136,671
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$2,246
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$4,200
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-09
|
$743,706
|
$252,860
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
1R41CA168107-01
|
$300,000
|
$150,000
|
McLaughlin, Jeffery
|
RADIANT CREATIVE GROUP, LLC
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$4,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$22,140
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$6,750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$565,715
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-10S1
|
$202,000
|
$40,400
|
FRONTERA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-10S2
|
$74,686
|
$14,937
|
FRONTERA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-10
|
$1,679,075
|
$335,815
|
LOPEZ-ENRIQUEZ, REYNOLD
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-10
|
$1,206,053
|
$241,211
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
$2,233
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
$42,830
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-10
|
$2,300,000
|
$2,300,000
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-28
|
$2,138,730
|
$21,387
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-08S1
|
$140,000
|
$26,600
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-08S2
|
$75,000
|
$14,250
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-08
|
$1,934,104
|
$367,480
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$341,697
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$2,997
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$4,492
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-05
|
$1,565,163
|
$78,258
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-25
|
$1
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-17S1
|
$74,994
|
$3,750
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-17S2
|
$49,998
|
$2,500
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-17
|
$1,249,323
|
$62,466
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIABC011220
|
$236,816
|
$94,726
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-03
|
$489,981
|
$244,991
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
5U54CA156734-03
|
$1,208,909
|
$604,455
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-09
|
$341,201
|
$3,412
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Tyrosine Kinase Signaling in Cancer Cell Metabolism
|
5R01CA140515-03
|
$315,144
|
$315,144
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
Total relevant funding to Leukemia for this search: $234,716,347
|
